Applied DNA Sciences (APDN)
(Real Time Quote from BATS)
$1.85 USD
-0.11 (-5.61%)
Updated May 21, 2024 02:44 PM ET
2-Buy of 5 2
C Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -1.51 |
EPS Last Quarter | -5.31 |
Last EPS Surprise | -15.43% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.54 |
Next Year | -2.41 |
EPS (TTM) | -17.11 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.95M | 1.00M | 3.77M | 5.80M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.95M | 1.00M | 3.77M | 5.80M |
Low Estimate | 0.95M | 1.00M | 3.77M | 5.80M |
Year ago Sales | 2.92M | 0.78M | 13.37M | 3.77M |
Year over Year Growth Est. | -67.47% | 28.21% | -71.80% | 53.85% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.51 | -0.92 | -6.54 | -2.41 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -1.51 | -0.92 | -6.54 | -2.41 |
High Estimate | -1.51 | -0.92 | -6.54 | -2.41 |
Low Estimate | -1.51 | -0.92 | -6.54 | -2.41 |
Year ago EPS | -4.80 | -5.20 | -15.20 | -6.54 |
Year over Year Growth Est. | 68.54% | 82.31% | 56.97% | 63.15% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -1.51 | -0.92 | -6.54 | -2.41 |
7 Days Ago | -1.51 | -0.92 | -6.54 | -2.41 |
30 Days Ago | -3.40 | -2.80 | -12.60 | -9.60 |
60 Days Ago | -3.40 | -2.80 | -12.60 | -9.60 |
90 Days Ago | -3.40 | -2.80 | -12.60 | -9.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.51 | -0.92 | -6.54 | -2.41 |
Zacks Consensus Estimate | -1.51 | -0.92 | -6.54 | -2.41 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -5.31 | -1.80 | -5.20 | -4.80 | NA |
Estimate | -4.60 | -6.20 | -5.40 | -4.80 | NA |
Difference | -0.71 | 4.40 | 0.20 | 0.00 | 0.97 |
Surprise | -15.43% | 70.97% | 3.70% | 0.00% | 14.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more